BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 16509569)

  • 41. Synthesis, structure, and biological activity of des-side chain analogues of 1α,25-dihydroxyvitamin D3 with substituents at C18.
    Verlinden L; Verstuyf A; Eelen G; Bouillon R; Ordóñez-Morán P; Larriba MJ; Muñoz A; Rochel N; Sato Y; Moras D; Maestro M; Seoane S; Dominguez F; Eduardo-Canosa S; Nicoletti D; Moman E; Mouriño A
    ChemMedChem; 2011 May; 6(5):788-93. PubMed ID: 21520419
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gene regulatory potential of 1alpha,25-dihydroxyvitamin D(3) analogues with two side chains.
    Bury Y; Herdick M; Uskokovic MR; Carlberg C
    J Cell Biochem Suppl; 2001; Suppl 36():179-90. PubMed ID: 11455583
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel 2-alkyl-1alpha,25-dihydroxy-19-norvitamin D3: efficient synthesis with Julia olefination, evaluation of biological activity and development of new analyzing system for co-activator recruitment.
    Arai MA; Kittaka A
    Anticancer Res; 2006; 26(4A):2621-31. PubMed ID: 16886672
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Applications of the Vitamin D sterol-Vitamin D receptor (VDR) conformational ensemble model.
    Mizwicki MT; Bishop JE; Norman AW
    Steroids; 2005; 70(5-7):464-71. PubMed ID: 15862832
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and structure-activity relationships of TEI-9647 derivatives as Vitamin D3 antagonists.
    Takenouchi K; Sogawa R; Manabe K; Saitoh H; Gao Q; Miura D; Ishizuka S
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):31-4. PubMed ID: 15225742
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiproliferative and calcemic actions of trans-decalin CD-ring analogs of 1,25-dihydroxyvitamin D3.
    Eelen G; Verlinden L; Laureys J; Marcelis S; De Clercq P; Mathieu C; Bouillon R; Verstuyf A
    Anticancer Res; 2009 Sep; 29(9):3579-84. PubMed ID: 19667151
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficient synthesis of 2-modified 1alpha,25-dihydroxy-19-norvitamin D3 with Julia olefination: high potency in induction of differentiation on HL-60 cells.
    Ono K; Yoshida A; Saito N; Fujishima T; Honzawa S; Suhara Y; Kishimoto S; Sugiura T; Waku K; Takayama H; Kittaka A
    J Org Chem; 2003 Sep; 68(19):7407-15. PubMed ID: 12968893
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 13,13-Dimethyl-des-C,D analogues of (20S)-1α,25-dihydroxy-2-methylene-19-norvitamin D₃ (2MD): total synthesis, docking to the VDR, and biological evaluation.
    Plonska-Ocypa K; Sibilska I; Sicinski RR; Sicinska W; Plum LA; DeLuca HF
    Bioorg Med Chem; 2011 Dec; 19(23):7205-20. PubMed ID: 22018918
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fine tuning of agonistic/antagonistic activity for vitamin D receptor by 22-alkyl chain length of ligands: 22S-Hexyl compound unexpectedly restored agonistic activity.
    Anami Y; Sakamaki Y; Itoh T; Inaba Y; Nakabayashi M; Ikura T; Ito N; Yamamoto K
    Bioorg Med Chem; 2015 Nov; 23(22):7274-81. PubMed ID: 26515040
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A new class of vitamin D analogues that induce structural rearrangement of the ligand-binding pocket of the receptor.
    Inaba Y; Yoshimoto N; Sakamaki Y; Nakabayashi M; Ikura T; Tamamura H; Ito N; Shimizu M; Yamamoto K
    J Med Chem; 2009 Mar; 52(5):1438-49. PubMed ID: 19193059
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and biological evaluation of 1α,25-dihydroxyvitamin D₃ analogues with a long side chain at C12 and short C17 side chains.
    Carballa DM; Seoane S; Zacconi F; Pérez X; Rumbo A; Alvarez-Díaz S; Larriba MJ; Pérez-Fernández R; Muñoz A; Maestro M; Mouriño A; Torneiro M
    J Med Chem; 2012 Oct; 55(20):8642-56. PubMed ID: 22989379
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5.
    Mehta RG; Moriarty RM; Mehta RR; Penmasta R; Lazzaro G; Constantinou A; Guo L
    J Natl Cancer Inst; 1997 Feb; 89(3):212-8. PubMed ID: 9017001
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Removal of C-ring from the CD-ring skeleton of 1alpha,25-dihydroxyvitamin D3 does not alter its target tissue metabolism significantly.
    Reddy GS; Robinson M; Wang G; Palmore GT; Gennaro L; Vouros P; De Clercq P; Vandewalle M; Young W; Ling S; Verstuyf A; Bouillon R
    Arch Biochem Biophys; 2007 Apr; 460(2):254-61. PubMed ID: 17196157
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation, and crystal structure.
    Shimizu M; Miyamoto Y; Takaku H; Matsuo M; Nakabayashi M; Masuno H; Udagawa N; DeLuca HF; Ikura T; Ito N
    Bioorg Med Chem; 2008 Jul; 16(14):6949-64. PubMed ID: 18539034
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis of 1alpha,25-dihydroxyvitamin D3-26,23-lactams (DLAMs), a novel series of 1 alpha,25-dihydroxyvitamin D3 antagonist.
    Kato Y; Nakano Y; Sano H; Tanatani A; Kobayashi H; Shimazawa R; Koshino H; Hashimoto Y; Nagasawa K
    Bioorg Med Chem Lett; 2004 May; 14(10):2579-83. PubMed ID: 15109656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential interaction of 1alpha,25-dihydroxyvitamin D3 analogues and their 20-epi homologues with the vitamin D receptor.
    Liu YY; Collins ED; Norman AW; Peleg S
    J Biol Chem; 1997 Feb; 272(6):3336-45. PubMed ID: 9013574
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Three-dimensional modeling of and ligand docking to vitamin D receptor ligand binding domain.
    Yamamoto K; Masuno H; Choi M; Nakashima K; Taga T; Ooizumi H; Umesono K; Sicinska W; VanHooke J; DeLuca HF; Yamada S
    Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1467-72. PubMed ID: 10677485
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and conformational analysis of 17alpha,21-cyclo-22-unsaturated analogues of calcitriol.
    Riveiros R; Rumbo A; Sarandeses LA; Mouriño A
    J Org Chem; 2007 Jul; 72(15):5477-85. PubMed ID: 17335235
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
    Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
    Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Conceptually new sulfone analogues of the hormone 1alpha, 25-dihydroxyvitamin D(3): synthesis and preliminary biological evaluation.
    Posner GH; Wang Q; Han G; Lee JK; Crawford K; Zand S; Brem H; Peleg S; Dolan P; Kensler TW
    J Med Chem; 1999 Sep; 42(18):3425-35. PubMed ID: 10479276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.